{"id":16565,"date":"2013-11-04T00:00:00","date_gmt":"2013-11-04T05:00:00","guid":{"rendered":"https:\/\/genomequebec.com\/actualites-et-publications\/new-study-to-determine-risk-of-down-syndrome\/"},"modified":"2013-11-04T00:00:00","modified_gmt":"2013-11-04T05:00:00","slug":"new-study-to-determine-risk-of-down-syndrome","status":"publish","type":"post","link":"https:\/\/genomequebec.com\/en\/news-and-publications\/new-study-to-determine-risk-of-down-syndrome\/","title":{"rendered":"New study to determine risk of Down syndrome"},"content":{"rendered":"<p>A team of\u00a0clinical\u00a0researchers led by CHU de Qu\u00e9bec and Universit\u00e9 Laval has received CAN$10.5 million from G\u00e9nome Qu\u00e9bec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects.\u00a0The four marker first trimester serum quadruple screen,1T-Quad (PAPP-A, Free beta hCG, AFP and PIGF) provided by <a href=\"http:\/\/www.perkinelmer.com\/?utm_source=businesswire&#038;utm_medium=press-release&#038;utm_campaign=DIAG-PR-Q3-13-NBScreening-CA\" target=\"_blank\" rel=\"noopener\">PerkinElmer<\/a> will be used by researchers to\u00a0validate its use in a contingent model where women identified by the 1T-Quad screen as having an increased risk of fetal aneuploidy undergo analysis of cell-free circulating\u00a0fetal DNA from a standard blood draw to better estimate their risk of Down syndrome or other trisomy.<\/p>\n<p>\u00a0<\/p>\n<p><a href='\/wp-content\/uploads\/data\/nouvelle\/147_en.pdf' download>T\u00e9l\u00e9charger le document<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A team of\u00a0clinical\u00a0researchers led by CHU de Qu\u00e9bec and Universit\u00e9 Laval has received CAN$10.5 million from G\u00e9nome Qu\u00e9bec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant&hellip;<\/p>\n","protected":false},"author":1,"featured_media":15453,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[294],"tags":[],"class_list":["post-16565","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/comments?post=16565"}],"version-history":[{"count":0,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/posts\/16565\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media\/15453"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=16565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/categories?post=16565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/tags?post=16565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}